As CFO, Mark is integral to the financial management, strategic direction and operational efficiency of FA Bio. Providing a combination of financial expertise, strategic vision and leadership skills, he is a key advisor to the senior management team on financial matters.
With over 25 years’ experience in financial management and a strong background in biotech and contract research, Mark is a valued and trusted advisor and executive team member. He also brings a wealth of board, executive and investor experience to provide high-quality strategic advice.
Mark has a passion for sustainability and supporting innovative and ambitious entrepreneurs and companies in bringing new innovative products to market by leveraging his skills and capabilities to help them achieve their goals.
Mark has previously worked at large international and small biotech companies, and was responsible for fundraising and licensing agreements, as well as commercial contract negotiations. Over his 8 years at AstraZeneca, he was Finance Director in a variety of areas including R&D Strategy, Discovery Sciences and Global Safety. More recently, Mark was CFO at Blueberry Therapeutics and is a Founding Director and Finance Leader at Integral Finance, an independent management consultancy providing tailored financial partnering services to high growth life science, healthcare, and technology businesses.
Mark is a CIMA qualified accountant and has a Masters in Psychology from the University of Edinburgh.

Contact